News about Global Pharma

PhotonPharma Receives USD 2.5 Million in Seed Funding Round

This vital funding will support the Phase I clinical trial of Innocell, an innovative therapy for the treatment of advanced ovarian cancer.

Global Pharma | 22/08/2024 | By Aishwarya |  663

BioMarin Strengthens its Leadership with New Appointments

At BioMarin, he will assume responsibility for the company's R&D organization, including discovery research, preclinical, translational and clinical programs, as well as global regulatory and medical affairs.

Global Pharma | 22/08/2024 | By Aishwarya |  737

Qubit Pharmaceuticals Receives Nomination for Best Start-Up 2024 Award

Qubit Pharmaceuticals, a deeptech company specializing in the discovery of new drug candidates through simulation and molecular modeling accelerated by hybrid HPC and quantum computing, has been nominated for the Prix Galien USA 'Best Startup Award'.

Global Pharma | 22/08/2024 | By Aishwarya |  563

Pathalys Pharma Bags USD 105 Million in Series B Financing

The funds raised via this financing will be utilized to finalize the two ongoing upacicalcet clinical trials, execution of the NDA filing process with the US Food and Drug Administration (FDA), and acceleration of preapproval commercialization preparations.

Global Pharma | 21/08/2024 | By Aishwarya |  700

Amneal Secures FDA Approval for Propofol Injectable Emulsion Single Dose Vials

Propofol is an intravenous drug commonly used in hospitals for the induction and maintenance of anesthesia and sedation.

Global Pharma | 21/08/2024 | By Aishwarya |  631

LMI and PharmaLogic to Supply Neuraceq in Denver

Neuraceq is an FDA-approved imaging agent for the detection of beta-amyloid plaques in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline.

Global Pharma | 21/08/2024 | By Aishwarya |  395

Vishnu Chemicals Announces Acquisition of Jayansree Pharma

Post-acquisition, JPPL will become a wholly-owned subsidiary of Vishnu Chemicals Limited, boosting the Group’s fixed asset by nearly INR 80 crore.

Global Pharma | 20/08/2024 | By Aishwarya |  1165

Titan Pharmaceuticals Enters into Merger Agreement with KE

Titan Pharmaceuticals, Inc. has signed a merger, contribution, and contribution and share exchange agreement, regarding a business combination with KE Sdn. Bhd. (KE).

Global Pharma | 20/08/2024 | By Aishwarya |  399

Sun Pharma to Invest Upto USD 15 Million for 5 Percent Stake in Pharmazz

Sun Pharma described the investment as strategic, noting it will gain exclusive rights to market and distribute Pharmazz’s drug, Sovateltide, in certain emerging markets.

Global Pharma | 17/08/2024 | By Aishwarya |  738

Lilly Completes Acquisition of Morphic

Morphic is a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases, including a selective oral small molecule inhibitor of α4β7 integrin (known as MORF-057) for inflammatory bowel disease (IBD).

Global Pharma | 17/08/2024 | By Aishwarya |  566